Tag: tumor microenvironment


  • Intratumoral vaccine: Chinese breakthrough in precision cancer

    Intratumoral vaccine: Chinese breakthrough in precision cancer

    New frontier in cancer treatment: the intratumoral vaccine concept A team of Chinese researchers has announced a pioneering approach to cancer therapy: an innovative intratumoral vaccine molecule designed to both unleash the immune system against tumors and protect immune memory. The strategy aims to stop cancer cells from suppressing immune responses and to redirect the…

  • Mapping metastasis: how nutrient availability shapes breast cancer’s spread

    Mapping metastasis: how nutrient availability shapes breast cancer’s spread

    Understanding how breast cancer metastasizes Breast cancer remains a leading cause of cancer-related mortality, in part because malignant cells can migrate from the primary tumor to distant organs. A growing body of research shows that where cancer cells settle is not random. The nutrient landscape of each organ—its available sugars, amino acids, lipids, and other…

  • The Dual Role of SLC7A11 in Colorectal Cancer Ferroptosis: A Molecular Tug-of-War

    The Dual Role of SLC7A11 in Colorectal Cancer Ferroptosis: A Molecular Tug-of-War

    Understanding Ferroptosis and SLC7A11 in Colorectal Cancer Colorectal cancer (CRC) remains a major global health challenge, driven by complex metabolic and genetic alterations. A relatively new area of cancer biology—ferroptosis—refers to an iron-dependent form of regulated cell death triggered by lipid peroxidation. At the center of this process lies SLC7A11, a cystine/glutamate antiporter, which plays…

  • Innovative Intratumoral Vaccine Molecule Paves Way for Precision Cancer Treatment

    Innovative Intratumoral Vaccine Molecule Paves Way for Precision Cancer Treatment

    Revolutionizing Cancer Immunotherapy with an Intratumoral Vaccine In a promising breakthrough from Shenzhen, Chinese scientists have developed an innovative molecule described as an intratumoral vaccine. This novel approach aims to stop cancer cells from suppressing the body’s immune response while simultaneously leveraging the body’s existing immune memory to target and attack tumors. If validated in…

  • Chinese Scientists Unveil Intratumoral Vaccine Molecule for Precision Cancer Therapy

    Chinese Scientists Unveil Intratumoral Vaccine Molecule for Precision Cancer Therapy

    Breakthrough in Precision Cancer Therapy Chinese researchers have announced a breakthrough in the fight against cancer with the development of an innovative “intratumoral vaccine” molecule. This cutting-edge approach aims to prevent cancer cells from dampening immune function while simultaneously directing the body’s existing immune memory to recognize and attack tumors. The discovery, developed by teams…

  • BATF2: Glutamine-Driven Silencing of a Novel Tumor Suppressor in Head and Neck Cancer

    BATF2: Glutamine-Driven Silencing of a Novel Tumor Suppressor in Head and Neck Cancer

    Introduction A groundbreaking study from researchers at The University of Texas MD Anderson Cancer Center reveals that BATF2, a newly identified tumor suppressor gene, is silenced by metabolic factors in the tumor microenvironment. Specifically, glutamine appears to suppress BATF2 activity, dampening the immune response against head and neck cancer in five preclinical models. This discovery…

  • BATF2: A Novel Tumor Suppressor Silenced by Glutamine in Head and Neck Cancer

    BATF2: A Novel Tumor Suppressor Silenced by Glutamine in Head and Neck Cancer

    Overview: BATF2 and its role in immune surveillance Researchers from The University of Texas MD Anderson Cancer Center have identified BATF2 as a novel tumor suppressor that helps coordinate immune responses against head and neck cancers. In healthy tissue, BATF2 is part of a transcriptional network that supports anti-tumor immunity. The new work reveals that,…

  • BATF2: A Glutamine-Driven Silencing of a Tumor Suppressor in Head and Neck Cancer

    BATF2: A Glutamine-Driven Silencing of a Tumor Suppressor in Head and Neck Cancer

    Overview: BATF2 as a Tumor Suppressor in Head and Neck Cancer BATF2 is emerging as a critical tumor suppressor whose activity helps mobilize the immune system against head and neck cancers. In preclinical studies led by researchers at The University of Texas MD Anderson Cancer Center, BATF2 function was consistently reduced in several models of…

  • Mark’s deadly cancer will come back. Now scientists know why

    Mark’s deadly cancer will come back. Now scientists know why

    Why cancer often returns Cancer can seem to disappear with surgery, chemotherapy, or radiation, only to come back months or years later. For patients and families, the question is not just “will it return?” but “why does it come back despite initial treatment?” Scientists are now piecing together a clearer picture of the biology behind…

  • Why Mark’s Deadly Cancer Could Return—and What Scientists Have Recently Uncovered

    Why Mark’s Deadly Cancer Could Return—and What Scientists Have Recently Uncovered

    Understanding the Fear of Recurrence When someone is told that cancer may come back, the news can feel like a ticking clock. For Mark Norris and countless others facing disease, the fear isn’t just about the present moment but about what happens next. In recent months, researchers have made meaningful strides in explaining why some…